about
Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public healthThe yellow fever vaccine: a historyDengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibodyDengue Plaque Reduction Neutralization Test (PRNT) in Primary and Secondary Dengue Virus Infections: How Alterations in Assay Conditions Impact PerformanceDevelopment of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeysVero cell platform in vaccine production: moving towards cell culture-based viral vaccines.Effects of a five-year citywide intervention program to control Aedes aegypti and prevent dengue outbreaks in northern Argentina.A traveler with rash and thrombocytopenia.Clinical and laboratory predictive markers for acute dengue infectionCost of dengue and other febrile illnesses to households in rural Cambodia: a prospective community-based case-control study.Climate change and infectious diseases in Australia: future prospects, adaptation options, and research priorities.DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III.The synergistic effect of combined immunization with a DNA vaccine and chimeric yellow fever/dengue virus leads to strong protection against dengue.Capillary leakage in travelers with dengue infection: implications for pathogenesisDengue vaccine: come let's fight the menace.Seasonal profiles of Aedes aegypti (Diptera: Culicidae) larval habitats in an urban area of Costa Rica with a history of mosquito control.Reduced risk of disease during postsecondary dengue virus infections.A review of vaccine approaches for West Nile virus.Recombinant vesicular stomatitis virus-based dengue-2 vaccine candidate induces humoral response and protects mice against lethal infection.Regional differences in the growing incidence of dengue Fever in Vietnam explained by weather variability.Salidroside exhibits anti-dengue virus activity by upregulating host innate immune factors.Update on imminent vaccines: report of the APPA VU 2010: II.An entomological surveillance system based on open spatial information for participative dengue control.Rational discovery of dengue type 2 non-competitive inhibitors.Flavivirus DNA vaccine with a kick.Larvicidal effect of dried leaf extracts from Pinus caribaea against Aedes aegypti (Linnaeus, 1762) (Diptera: Culicidae).Immunological serotype interactions and their effect on the epidemiological pattern of dengue.Dengue-Virus-Infektionen
P2860
Q24289308-CE939143-4643-4A87-9E4F-33B979DDC21EQ24628075-CD1C37CF-96D6-435D-98E3-E1BF27F05640Q27489654-B12EA1E3-39ED-46F6-92FC-897D9FABDBCDQ27491036-0EC3BC83-AB30-414E-A42E-B1C26C1F10E7Q27491049-C44F7DC5-D75B-4AE5-9435-FE173AEBA1EFQ30376550-34B1F164-DAD2-45D9-93FB-6DA47B5779F0Q30397682-ECB9588B-721D-453C-B30A-AC208BD1B340Q33382119-930D6F78-0F99-40EC-872E-5A85F41C955CQ33411022-BC45ED65-6B43-4266-88BF-8D1573A0B5ACQ33453934-06F4CA78-D0FD-4800-9547-8A3C5895324DQ33857372-AE2F698E-7FFF-42A8-9232-466DF5908F19Q33968024-21565D8C-3D29-4D5A-887C-83F62FE8D696Q34614953-FD5536ED-EA9F-4FC8-98F5-2932FDD252ADQ35771848-CAC2FE70-8C29-4FED-87F0-70DC696DD8A1Q35887206-84813EA0-86C8-4F55-BED3-C2BC32D96AE4Q36920510-24E998A1-FCA7-46E4-BAB8-27527FF64049Q37109553-AFEFEA14-58A7-41E9-B13B-CDEEA6114AB4Q37236968-6928885E-774E-4AA6-A10A-B8C8BF6AB646Q37265013-54364D79-E645-4CDC-AFAF-016BBD4BBAC5Q37663274-D7B5DADF-5A1E-43F4-AC55-733F9ECEFDE8Q38748779-D3B9E675-3ADE-4850-B6D1-2021575C56AEQ39775694-D73FC7D7-B6C1-4018-985B-09FE1836E4D7Q39906731-4614C637-4D2B-402E-8400-9D535B296807Q40256995-5953DEC4-0C47-45BF-8B12-D2AAC1FFA495Q42978304-3937EFB9-55AB-41C6-B724-32B11D4699E0Q42991524-118C71E7-5ECB-4C58-AC53-DE5C5DCC39C4Q51131051-61B11454-EF23-4D2A-9FDF-0EA182BEE9B8Q55109773-56760428-AB55-412A-A338-346896E29D90
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Dengue vaccines approach the finish line.
@ast
Dengue vaccines approach the finish line.
@en
Dengue vaccines approach the finish line.
@nl
type
label
Dengue vaccines approach the finish line.
@ast
Dengue vaccines approach the finish line.
@en
Dengue vaccines approach the finish line.
@nl
prefLabel
Dengue vaccines approach the finish line.
@ast
Dengue vaccines approach the finish line.
@en
Dengue vaccines approach the finish line.
@nl
P356
P1476
Dengue vaccines approach the finish line.
@en
P2093
Robert Edelman
P304
P356
10.1086/518148
P407
P478
45 Suppl 1
P577
2007-07-01T00:00:00Z